MELA, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 5.014
Totale 5.014
Nazione #
IT - Italia 5.014
Totale 5.014
Città #
Genova 3.816
Rapallo 562
Genoa 422
Vado Ligure 213
Bordighera 1
Totale 5.014
Nome #
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD) 150
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. 145
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 131
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 131
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 128
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 128
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 124
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 124
Acid and gastric metaplasia in the duodenum 123
A comparison of five maintenance therapies for reflux esophagitis 122
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 120
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 118
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 116
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 115
Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. 113
Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. 107
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 105
The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients. 104
Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? 103
Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? 101
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. 99
Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment. 98
Once-Daily Bedtime Dose of Roxatidine and Ranitidine in Acute Duodenal Ulcer: A Combined Assessment of Acid Inhibitory Activity and Healing Rate. 97
Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. 95
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer. 93
Duodenal ulcer resistant to usual omeprazole dose. 91
24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. 90
Duration of acid suppression in H2-antagonist nonresponders. 87
24-hour gastric pH-metry analysis: influence of arbitrarily predefined time intervals on the reliability of acidity indexes. 87
Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. 86
Ulcer heterogeneity: further arguments for a range of antisecretory treatment. 86
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori. 86
Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring. 85
Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. 85
Influence of sampling rate in 24 hour gastric pH-metry analysis. 84
Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg. 83
Pharmacodynamics of famotidine in gastric ulcer. 82
[Esophageal pH monitoring: factors influencing the definition of normality]. 82
Intragastric acidity and serum gastrin after sufotidine. 82
Analysis of circadian fluctuations of bile salt concentration and pH in the stomach of normal subjects and patients suspected of having duodenogastric reflux. 80
Mealtime versus nighttime acid inhibition. A clinical pharmacological study with ranitidine. 79
Circadian gastric acidity and Helicobacter pylori infection in patients with chronic pancreatitis. 78
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. 77
Effect of Helicobacter pylori eradication on 24-hour gastric pH and duodenal gastric metaplasia. 76
Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients. 76
Bolus infusion of famotidine: effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients. 75
Circadian acidity pattern in gastric ulcers at different sites. 74
Once or twice daily doses of proton pump inhibitor in treating Barrett's esophagus? 73
Continuous acidity monitoring in the study of gastric antisecretory drugs: pH or antilog transformation of pH, mean or median? 71
Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study. 63
Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy. 62
Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients. 44
Totale 5.014
Categoria #
all - tutte 13.512
article - articoli 11.095
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 2.417
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.024


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.108 0 0 0 0 124 131 213 76 110 242 147 65
2020/2021244 21 19 20 19 20 12 22 16 40 28 15 12
2021/2022539 14 51 25 90 13 40 61 87 25 53 16 64
2022/2023666 66 47 9 63 137 97 0 28 116 3 94 6
2023/2024284 9 34 8 31 16 44 10 11 29 3 30 59
2024/2025248 47 72 23 47 59 0 0 0 0 0 0 0
Totale 5.014